AspenTech Logo

News Release

View printer-friendly version
<< Back

AspenWorld 2002 to Address Key Pharmaceutical Industry Challenges and Trends

08/08/02

Senior management from the world's top drug makers offer counsel on improving profitability through innovation in business processes and technology

CAMBRIDGE, Mass., Aug. 8 /PRNewswire-FirstCall/ -- Aspen Technology, Inc. (Nasdaq: AZPN) today announced additions to its distinguished roster of pharmaceutical industry speakers at AspenWorld 2002, the process industry's leading conference taking place Oct. 27 through Nov. 1 in Washington, DC. Among them is Dr. Mike J. Dey, Head of the Aventis Pharma Lead Technology & Engineering Centre, who will address new product development and the manufacturing considerations associated with it. Jack Welch, the former Chairman and CEO of General Electric, will present the conference keynote address to 2,500 executives attending from over 50 countries.

(Photo: http://www.newscom.com/cgi-bin/prnh/20000811/ASPENLOGO )

AspenWorld 2002 will provide information on the industry topics of most concern to decision makers from the world's leading pharmaceutical companies, as well as covering key issues from the petroleum, chemical and other process industries. Speakers will address industry trends around the globe, successful technology initiatives and opportunities to maximize profit. Other leading speakers within the pharmaceutical industry track include Dr. G.K. Raju, Executive Director, MIT Pharmaceutical Manufacturing Initiative (PHARMI), who will address the current state of pharmaceutical manufacturing followed by tomorrow's manufacturing opportunities. His presentation is one of more than 400 presentations that will be given in more than 80 sessions. The pharmaceutical track presenters also include:

  • Dr. Carlo Guy, Project Manager, Baxter Bioscience, addressing supply chain implementation at Baxter

  • Dan Heighway, Manager, Data/Strategy Global Supply IT, Eli Lily and Company, discussing the impact of information technology on pharmaceutical manufacturing

  • Doug Long, Vice President, Industry Relations, IMS Health, addressing worldwide industry issues

  • Dr. David Selby, Independent Consultant, David Begg Associates, explaining the history behind regulations and why the pharmaceutical industry needs them

  • Roddy Martin, Research Director, Consumer Goods and Life Sciences Manufacturing, AMR Research, who will show pharmaceutical executives how to "Follow the Money in the Supply Chain"

  • Stuart J. Norman, NPS Director, GlaxoSmithKline, discussing "GSK: phNPD Business Process and Future Trends"

"At AspenWorld 2002, pharmaceutical industry executives will learn how to overcome industry-specific challenges that affect their competitive positioning, ranging from increasing demand for New Chemical Entities to declining windows of exclusivity for new compounds," said Larry Evans, Chairman and CEO of AspenTech. "AspenWorld will offer senior leadership new perspectives on how to reduce time to market and improve overall profitability through collaborative manufacturing and optimization of their value chain."

Panels in the pharmaceuticals session will focus on industry trends and future directions, achieving manufacturing excellence, adaptive pharmaceutical supply chains, regulatory mandates, and product life cycle management and new product development. More information on AspenWorld 2002 and its presenters is available at https://www.aspenworld2002.com/pharma/awpharma.asp.

About AspenTech

Aspen Technology, Inc. is a leading supplier of enterprise software to the process industries. AspenTech's industry solutions enable companies to maximize their profitability by running their manufacturing and supply chain operations more efficiently, and by increasing the returns from their plant assets. Over 1,200 leading companies already rely on AspenTech's 21 years of process industry experience to increase revenues, reduce costs and improve capital efficiency. AspenTech's customers include: Air Liquide, AstraZeneca, Bayer, BASF, BP, ChevronTexaco, Dow Chemical, DuPont, ExxonMobil, GlaxoSmithKline, Lyondell Equistar, Merck, Mitsubishi Chemical, Shell and Unilever. For more information, visit www.aspentech.com.

Certain paragraphs of this press release contain forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statement using the term "will," "should," "could," "anticipates," "believes" or a comparable term is a forward-looking statement. Actual results may vary significantly from AspenTech's expectations based on a number of risks and uncertainties, including: AspenTech's lengthy sales cycle which makes it difficult to predict quarterly operating results; fluctuations in AspenTech's quarterly operating results; AspenTech's dependence on customers in the cyclical chemicals, petrochemicals and petroleum industries; AspenTech's need to hire additional qualified personnel and its dependence on key current employees; intense competition; AspenTech's dependence on systems integrators and other strategic partners; changes in the market for e-business solutions for AspenTech's customers; increased governmental regulation and taxation of e-commerce and the Internet; information security and privacy concerns relating to e-commerce; and other risk factors described from time to time in AspenTech's periodic reports and registration statements filed with the Securities and Exchange Commission. AspenTech cannot guarantee any future results, levels of activity, performance, or achievements. Moreover, neither AspenTech nor anyone else assumes responsibility for the accuracy and completeness of any forward-looking statements. AspenTech undertakes no obligation to update any of the forward-looking statements after the date of this press release.

AspenTech, Aspen ProfitAdvantage, Plantelligence and the aspen leaf logo are trademarks of Aspen Technology, Inc., Cambridge, Mass.

     Contacts:

     For Media:
     Peter Watt                    Carin Warner
     Aspen Technology, Inc.        Warner Communications
     +44 1223 819-752              (978) 526-1960
     peter.watt@aspentech.com      carin@warnerpr.com

For Investors:

Joshua Young

Aspen Technology, Inc.

(617) 949-1274

joshua.young@aspentech.com

SOURCE Aspen Technology, Inc.

-0- 08/08/2002

CONTACT:
Media: Peter Watt of Aspen Technology, Inc.,
+44 1223 819-752, peter.watt@aspentech.com; or Carin Warner of Warner
Communications, +1-978-526-1960, carin@warnerpr.com; or Investors: Joshua
Young of Aspen Technology, Inc., +1-617-949-1274, joshua.young@aspentech.com

/Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20000811/ASPENLOGO

AP Archive: http://photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 212-782-2840/